Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (Q22241905)

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Ventilator-associated pneumonia: caveats for benchmarking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effect of ventilator-associated pneumonia on mortality and morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Epidemiology of nosocomial pneumonia. New perspectives on an old disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Increasing prevalence of antimicrobial resistance in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Emerging carbapenemases in Gram-negative aerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Molecular aspects of methicillin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Potable water supply as the hospital reservoir for Pittsburgh pneumonia agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of Legionnaires' disease. Current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Prognostic factors of severe Legionella pneumonia requiring admission to ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Aspergillus Infection After Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial Respiratory Syncytial Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effectiveness of influenza vaccine in health care professionals: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Prophylaxis and treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Controversies on diagnosis and prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Implications of endotracheal tube biofilm for ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Syncope and orthostatic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Noninvasive positive-pressure ventilation for respiratory failure after extubation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Noninvasive versus conventional mechanical ventilation. An epidemiologic survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nurse-Staffing Levels and the Quality of Care in Hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Pneumonia in intubated patients: role of respiratory airway care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Utility of selective digestive decontamination in mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Enteral nutrition in patients receiving mechanical ventilation. Multiple sources of tracheal colonization include the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Double-blind study of selective decontamination of the digestive tract in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Changing bacterial ecology during a five-year period of selective intestinal decontamination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Bacteriological side effects of gut decontamination with polymyxin E, gentamicin, and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Mechanisms of failure to decontaminate the gut with polymixin E, gentamicin and amphotericin B in patients in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Risk Factors for Developing Pneumonia within 48 Hours of Intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The gastropulmonary route of infection--fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Antimicrobial resistance in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The Radiologic Diagnosis of Autopsyproven Ventilator-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Diagnosing ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Tracheal aspirate correlates with protected specimen brush in long-term ventilated patients who have clinical pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Decision making in nosocomial pneumonia. An analytic approach to the interpretation of quantitative bronchoscopic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Clinical significance of borderline quantitative protected brush specimen culture results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Blinded invasive diagnostic procedures in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

The pharmacology of meropenem, a new carbapenem antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Maintaining fluoroquinolone class efficacy: review of influencing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Pneumonia in the surgical intensive care unit: factors determining successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Is there a role for antibiotic cycling in the intensive care unit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

What is the natural history of resolution of nosocomial pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

A Controlled Trial in Intensive Care Units of Selective Decontamination of the Digestive Tract with Nonabsorbable Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 Blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

Improving empiric antibiotic selection using computer decision support

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Noninvasive positive pressure ventilation in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Changing a hydrophobic heat and moisture exchanger after 48 hours rather than 24 hours: a clinical and microbiological evaluation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Influenza control in acute care hospitals

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Exposure to allogeneic plasma and risk of postoperative pneumonia and/or wound infection in coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A computer-assisted management program for antibiotics and other antiinfective agents

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nursing home-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial legionellosis associated with aspiration of nasogastric feedings diluted in tap water

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Devising strategies for preventing nosocomial pneumonia--should we ignore the stomach?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Is ventilator-associated pneumonia an independent risk factor for death?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Selective decontamination of the digestive tract in the intensive care unit: current status and future prospects

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Safety, efficacy, and cost-effectiveness of mechanical ventilation with humidifying filters changed every 48 hours: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial pneumonia in patients undergoing heart surgery

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Prolonged use of heat and moisture exchangers: why do we keep changing things?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnosis of pneumonia in mechanically ventilated patients. Repeatability of the protected specimen brush

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial pneumonia in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Etiology of severe pneumonia in the very elderly

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Recurrent Pseudomonas aeruginosa Pneumonia in an Intensive Care Unit

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Fibroproliferation in late adult respiratory distress syndrome. Pathophysiology, clinical and laboratory manifestations, and response to corticosteroid rescue treatment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Diagnosis and treatment of ventilator-associated pneumonia--impact on survival. A decision analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal t

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier with heated-water humidification in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Transfusion of Blood Components and Postoperative Infection in Patients Undergoing Cardiac Surgery

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Health care--associated bloodstream infections: a change in thinking

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Control of influenza in the hospital

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

Multiple organ system failure and infection in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-644ST

7 January 2021

10.1164/RCCM.200405-644ST

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

71055

71055

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference